Andrew Aromando - Chief Operating Officer at Ambrx Biopharma Cayman, Inc.

Issuer-level insider activity

Role
Chief Operating Officer
Issuer ticker
AMAM
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Andrew Aromando since 08 Oct 2025

Reported holdings for Andrew Aromando in Ambrx Biopharma Cayman, Inc.

Form 4 holding Chief Operating Officer

Ambrx Biopharma Inc.

Security class
Stock Option (right to buy)
Shares / value
389,000
Estimated value
Report date
05 Jul 2023
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Transaction history for Andrew Aromando in Ambrx Biopharma Cayman, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .